Search details
1.
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death.
J Biol Chem
; 298(4): 101821, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35283189
2.
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
J Biol Chem
; 298(4): 101817, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35278434
3.
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors.
J Biomed Sci
; 29(1): 86, 2022 Oct 25.
Article
in English
| MEDLINE | ID: mdl-36284291
4.
The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells.
J Immunol
; 189(2): 567-74, 2012 Jul 15.
Article
in English
| MEDLINE | ID: mdl-22664873
5.
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Int J Cancer
; 132(6): 1341-50, 2013 Mar 15.
Article
in English
| MEDLINE | ID: mdl-22907255
6.
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Am J Cancer Res
; 13(4): 1209-1239, 2023.
Article
in English
| MEDLINE | ID: mdl-37168336
7.
An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response.
STAR Protoc
; 3(1): 101198, 2022 03 18.
Article
in English
| MEDLINE | ID: mdl-35243381
8.
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.
Cancer Res
; 82(11): 2185-2195, 2022 06 06.
Article
in English
| MEDLINE | ID: mdl-35385574
9.
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
Nat Cancer
; 3(10): 1211-1227, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36253486
10.
Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.
Am J Cancer Res
; 11(1): 236-250, 2021.
Article
in English
| MEDLINE | ID: mdl-33520371
11.
Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERα expression in high-grade serous ovarian carcinoma.
Am J Cancer Res
; 10(4): 1194-1206, 2020.
Article
in English
| MEDLINE | ID: mdl-32368395
12.
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.
Am J Cancer Res
; 10(2): 648-661, 2020.
Article
in English
| MEDLINE | ID: mdl-32195033
13.
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nat Commun
; 11(1): 673, 2020 Jan 29.
Article
in English
| MEDLINE | ID: mdl-31996688
14.
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.
Cancer Res
; 79(4): 819-829, 2019 02 15.
Article
in English
| MEDLINE | ID: mdl-30573522
15.
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells.
Am J Cancer Res
; 9(3): 608-618, 2019.
Article
in English
| MEDLINE | ID: mdl-30949414
16.
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nat Commun
; 10(1): 5114, 2019 11 08.
Article
in English
| MEDLINE | ID: mdl-31704972
17.
Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
Cell Death Dis
; 8(11): e3167, 2017 11 09.
Article
in English
| MEDLINE | ID: mdl-29120412
18.
Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
Clin Cancer Res
; 23(2): 503-513, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27435393
19.
IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia.
J Leukoc Biol
; 99(1): 131-41, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26342105
20.
Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a.
Mol Neurobiol
; 53(6): 4173-4188, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26208701